Dr. Vineet Kacker, Managing Director and Global Technical Head, APCER Life Sciences will be presenting on ‘Patient safety as part of your clinical development strategy’ with key focus on:
- Major safety challenges with cellular therapies
- Need for Pharmacovigilance in strategizing the safety requirements for Cellular therapies
- Risk monitoring considerations and
- Building a predictive and responsive safety strategy for cellular products.
We are excited to participate at the ‘in person’ Onco Cell Therapy Summit!
Visit our booth#11 to interact with our experts on how you can meet your regulatory and drug safety commitments for your Advanced Therapy Medicinal Products.
About Onco Cell Therapy Summit
The Onco Cell Therapy Summit (OCTS), November 16 – 18, Boston USA, brings together all the industry experts to share insights around novel research, manufacturing and regulatory best practices for advanced medicinal products in the oncology field.
Significant break throughs in the use of alternative cell therapies in oncology are showing promising results in delivering positive patient outcomes. However, with current treatments still having high costs of use and as there are limited patient pools, there are still challenges in both clinical and commercial use of these therapies.
This conference largely focusses on such breakthrough therapies, advancements and commercialization of research into safe and efficacious therapies to address these challenges.